North Dakota Technology Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on North Dakota Technology Review.

Press releases published on June 1, 2026

Jun. 1, 2026

reAlpha (NASDAQ: AIRE) to Host “AIRE Time With Mike” Fireside Chat Moderated by Benchmark Analyst Daniel Kurnos

Indeterminate GlobeNewswire

Jun. 1, 2026

Disc Medicine Launches Expanded Access Program for Bitopertin for EPP Patients

Indeterminate GlobeNewswire

Jun. 1, 2026

Wave Life Sciences to Present at Upcoming Investor Conferences

Indeterminate GlobeNewswire

Jun. 1, 2026

Oak Hill Bio Raises $32.5 Million Series A Financing to Advance Antisense Oligonucleotide Therapy Rugonersen to Phase 3 Study in Angelman Syndrome

Indeterminate GlobeNewswire

Jun. 1, 2026

JET.AI ANNOUNCES LEADING INDEPENDENT PROXY ADVISORY FIRM GLASS LEWIS RECOMMENDS STOCKHOLDERS VOTE “FOR” THE PROPOSED MERGER

Indeterminate GlobeNewswire

Jun. 1, 2026

IN8bio Presents Updated Overall Survival Data Surpassing 19.5 Months for DeltEx DRI in Newly Diagnosed Glioblastoma at ASCO 2026

Indeterminate GlobeNewswire

Jun. 1, 2026

How Advanced Drug Delivery Could Improve Existing Cancer Treatments

Indeterminate GlobeNewswire

Jun. 1, 2026

AI’s Power Crisis Is Accelerating a Potential $2.5 Trillion Hydrogen Market

Indeterminate GlobeNewswire

Jun. 1, 2026

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 1, 2026

Fate Therapeutics Showcases Clinical Data for FT836 at the American Society of Cancer Oncology Annual Meeting

Indeterminate GlobeNewswire

Jun. 1, 2026

America’s Housing Crisis Fuels Demand for Affordable, Factory-Built Home Innovation

Indeterminate GlobeNewswire

Jun. 1, 2026

Cosmos Health Enters $69 Billion Global Animal Health Industry with Veterinary C-Scrub Wash 4% Following Successful European Standard Testing Under EN 1656 and EN 1657

Indeterminate GlobeNewswire

Jun. 1, 2026

Vaxart Files Definitive Proxy Statement and Mails Letter to Shareholders

Indeterminate GlobeNewswire

Jun. 1, 2026

Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at ASCO Meeting 2026

Indeterminate GlobeNewswire

Jun. 1, 2026

Ealixir Expands Media Presence Through Affaritaliani Regional Publishing Initiative

Indeterminate GlobeNewswire

Jun. 1, 2026

Cellectar Biosciences to Highlight Compelling New Efficacy Data from Phase 2b CLOVER WaM Study of Iopofosine I 131 in r/r Waldenström Macroglobulinemia at the American Society of Clinical Oncology Annual Meeting

Indeterminate GlobeNewswire

Jun. 1, 2026

NurExone Announces First Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Jun. 1, 2026

Immatics Presents Clinical Activity and Response Dynamics of Anzu-cel PRAME Cell Therapy at 2026 ASCO Annual Meeting

Indeterminate GlobeNewswire

Jun. 1, 2026

Dr. Falk Pharma and Renexxion Proceed to Late-Stage Development of Naronapride, Moving Towards Approval in the US and Europe, Following Positive Global Phase 2b Results in Gastroparesis

Indeterminate GlobeNewswire

Jun. 1, 2026

Amneal to Participate in Goldman Sachs 47th Annual Global Healthcare Conference 2026

Indeterminate GlobeNewswire